Open Access Study protocol

An Australian translational Study to evaluate the prognostic role of inflammatory markers in patients with metastatic ColorEctal caNcer Treated with bevacizumab (Avastin™) [ASCENT]

Stephen Clarke*, Matt Burge, Cassandra Cordwell, Peter Gibbs, William Reece and Niall Tebbutt

BMC Cancer 2013, 13:120  doi:10.1186/1471-2407-13-120

Article Metrics

1651
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 55 accesses
  • Last 365 days: 699 accesses
  • All time: 1651 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information